Contract Development and Large-Scale Manufacturing of Biopharmaceuticals
- Company Details
- Products & Services
- White Papers
- Press Releases
- Regional Offices
- Contact Company
Boehringer Ingelheim Wins 2011 European Bio Pharmaceutical Contract Manufacturing Competitive Strategy Leadership Award
Boehringer Ingelheim is pleased to announce that it has received the Frost & Sullivan '2011 European Bio Pharmaceutical Contract Manufacturing Competitive Strategy Leadership Award'. ...
Boehringer Ingelheim and ProBioGen Sign Licensing Agreement for GlymaxX® Technology
Boehringer Ingelheim and ProBioGen have signed a non-exclusive licensing agreement regarding ProBioGen's GlymaxX® technology. Boehringer Ingelheim's Contract Manufacturing Business will...
Boehringer Ingelheim Expands Biopharmaceutical Fill and Finish Capabilities
Boehringer Ingelheim is expanding its capacities and capabilities in fill and finish for biopharmaceuticals at its state-of-the-art facility in Biberach, Germany, with a new filling line. The...
Boehringer Ingelheim and Bayer HealthCare Extend Commercial Production Agreement for Betaferon®
Boehringer Ingelheim is pleased to announce the US-registration for manufacturing of Bayer HealthCare's Betaferon® against multiple sclerosis. Recently Bayer HealthCare has extended...
Pfenex and Boehringer Ingelheim Enter into Strategic Agreement for Pfenex Expression Technology
Pfenex, an industry leader in protein expression through the Pfenex Expression Technology platform, and Boehringer Ingelheim International, a leading pharmaceutical company and global...
Boehringer Ingelheim Collaborates with VTU Technology to Provide Customers with a Broader Range of Contract Services
Boehringer Ingelheim, a global leader in biopharmaceutical contract development and manufacture, and VTU Technology, a leading supplier of exclusive technologies and comprehensive services for...